SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Female Health FHCO
VERU 2.560+0.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Glenn Petersen3/11/2015 11:04:02 AM
   of 211
 
The Female Health Company Launches Online Store for Direct-to-Consumer Sales

Online Purchasing Represents A Key Element in U.S. Consumer Strategy

CHICAGO, March 11, 2015 /PRNewswire/ -- The Female Health Company (NASDAQ - CM: FHCO), maker of the FC2 Female Condom®, today announced the launch of its online store for Direct-to-Consumer retail purchases. The store can be accessed through the Company's website at http://femalehealth.com/ or directly at http://www.shopfemalehealth.com, and a link to the store is available on partner family planning organization websites.

The FC2 Female Condom offers a non-hormonal birth control option under a woman's control that also protects against sexually-transmitted diseases. The only other dual protection option available today is the male condom. Couples who routinely use male condoms often report a surprising satisfaction level when they try FC2 Female Condom due to a more natural and less restrictive sensation.

"FC2 is made of nitrile polymer, which enhances heat transfer, and the loose fitting sheath adheres to the vaginal wall," noted Karen King, President and Chief Executive Officer of The Female Health Company. "Combined, these features lead to a more natural feel when compared to male latex condoms. FC2, which is available in over 144 countries, has been embraced by women around the world but is not well known in the United States. Our recent market research has shown that women are generally unsatisfied with the side effects of hormonal birth control, which often include weight gain, mood disorders and other significant issues. These side effects are exacerbated by the fact that hormonal birth control products are often taken for years. We believe it is time for women in the U.S. to learn about our non-hormonal option, which eliminates such side effects while offering users a more satisfying option to male condoms."

"We are implementing direct-to-consumer initiatives in multiple markets, including the U.S., Europe and South Africa," continued King. "This represents an important element in our Company's growth strategy, which is focused on driving FC2 utilization and introducing portfolio diversification. We continue to make progress on all fronts towards the implementation of this strategy and remain committed to building long term value for our investors and customers around the world."

The FC2 Female Condom is available to U.S. consumers online through Walgreens.com, Drugstore.com, and now directly from The Female Health Company. Consumers can also join the FC2 social networking community on Facebook, Twitter, YouTube, Google+ and Instagram. Support materials, health and wellness updates and shared experiences can also be accessed through these venues.

In other news, The Female Health Company is progressing well with the delivery of its previously announced and significant Brazil Ministry of Health order. "The strength of our existing business is generating cash to support our growth and portfolio diversification initiatives. As we previously indicated, the majority of the Brazil order will ship in the current fiscal quarter, which we expect to be one of the strongest volume quarters in the Company's history," concluded King.

<snip>

finance.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext